Ascendis Pharma AS (ASND) Annual Income Statement (USD)
ASND Quarterly Financials (USD)
Frequently Asked Questions About Ascendis Pharma AS (ASND) Stock
Ascendis Pharma AS's (ASND) last reported annual revenue was USD 266.72 Million.
Ascendis Pharma AS's (ASND) annual revenue growth rate based on the revenue reported in the past 5 years is : 90.68%
Ascendis Pharma AS's(ASND) is not profitable as of its last reported annual financials.
The net profit margin for Ascendis Pharma AS's(ASND) from its laster reported year is -180.51%
The return on equity (ROE) for Ascendis Pharma AS's(ASND) from its last reported annual financials is : -818.43%
The return on assets (ROA) for Ascendis Pharma AS's(ASND) from its last reported annual financials is : -27.92%
The return on invested capital (ROIC) for Ascendis Pharma AS's(ASND) from its last reported annual financials is : -79.02%
The Debt to Equity ratio for Ascendis Pharma AS's(ASND) from its last reported annual financials is : -366.68%
The dividend yield for Ascendis Pharma AS's(ASND) from its laster reported year is 0.00%
Ascendis Pharma AS's(ASND) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASND !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
